nifedipine has been researched along with Hypertensive Retinopathy in 3 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Hypertensive Retinopathy: Degenerative changes to the RETINA due to HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nifedipine and irbesartan were taken after discharge, and the dosage was reduced gradually under supervision." | 1.48 | Hypertensive crisis with 2 target organ impairment induced by glycyrrhizin: A case report. ( Fan, X; Li, J; Wang, Q, 2018) |
| "Efforts to increase the awareness and treatment of hypertension in the population at large may lower the incidence of hypertensive crisis and its complications." | 1.37 | Dutch guideline for the management of hypertensive crisis -- 2010 revision. ( Beutler, JJ; de Gooijer, A; Gaillard, CA; Kroon, AA; van den Born, BJ; van den Meiracker, AH, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Fan, X | 1 |
| Wang, Q | 1 |
| Akal, A | 1 |
| Adibelli, MF | 1 |
| Karakas, EY | 1 |
| Ulas, T | 1 |
| van den Born, BJ | 1 |
| Beutler, JJ | 1 |
| Gaillard, CA | 1 |
| de Gooijer, A | 1 |
| van den Meiracker, AH | 1 |
| Kroon, AA | 1 |
3 other studies available for nifedipine and Hypertensive Retinopathy
| Article | Year |
|---|---|
Hypertensive crisis with 2 target organ impairment induced by glycyrrhizin: A case report.
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cholangitis; | 2018 |
Papilledema in a Hypertensive Adult With Grade 4 Retinopathy.
Topics: Adolescent; Antihypertensive Agents; Calcium Channel Blockers; Enalapril; Follow-Up Studies; Humans; | 2015 |
Dutch guideline for the management of hypertensive crisis -- 2010 revision.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calc | 2011 |